Cargando…
The Protein Corona as a Confounding Variable of Nanoparticle-Mediated Targeted Vaccine Delivery
Nanocarriers (NC) are very promising tools for cancer immunotherapy. Whereas conventional vaccines are based on the administration of an antigen and an adjuvant in an independent fashion, nanovaccines can facilitate cell-specific co-delivery of antigen and adjuvant. Furthermore, nanovaccines can be...
Autores principales: | Bros, Matthias, Nuhn, Lutz, Simon, Johanna, Moll, Lorna, Mailänder, Volker, Landfester, Katharina, Grabbe, Stephan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6082927/ https://www.ncbi.nlm.nih.gov/pubmed/30116246 http://dx.doi.org/10.3389/fimmu.2018.01760 |
Ejemplares similares
-
Unraveling the In Vivo Protein Corona
por: Simon, Johanna, et al.
Publicado: (2021) -
Endosomal sorting results in a selective separation of the protein corona from nanoparticles
por: Han, Shen, et al.
Publicado: (2023) -
RhoA as a Key Regulator of Innate and Adaptive Immunity
por: Bros, Matthias, et al.
Publicado: (2019) -
Nanodrugs Targeting T Cells in Tumor Therapy
por: Haist, Maximilian, et al.
Publicado: (2022) -
Protein Corona: Prevention of Dominant IgG Adsorption on Nanocarriers in IgG‐Enriched Blood Plasma by Clusterin Precoating (Adv. Sci. 10/2019)
por: Prozeller, Domenik, et al.
Publicado: (2019)